Authors


Kayla Stover, PharmD, BCIDP, BCPS, FCCP, FIDSA

Latest:

Top 5 Tips for Teaching ID Learners

The latest article from SIDP offers a Top 5 list of how to precept a learner on an infectious disease rotation.


Brian Lu, PharmD

Latest:

Combination Antifungal for Invasive Mucormycosis: Yay or Nay?

There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.


Zahra Qamar, MD; Steven F. Solga, MD; and Lisa A. Spacek, MD, PhD, FIDSA

Latest:

NAFLD Is Increasingly Affecting Patients With HIV

The prevalence of this disease in this patient population is much higher than in the general public.


Sonal Patel, PharmD, BCIDP

Latest:

SPREADing the Love: The Importance of Mentorship in Pharmacy

In the latest column from SIDP, the authors discuss having leaders to help navigate school and beyond.


Esther Esadah, PharmD

Latest:

The Role of Pharmacists in the World of Pediatric Antimicrobial Stewardship

The limitation in the number of pediatric-specific guidelines by professional organizations, and results from large randomized clinical trials, may place an additional emphasis on literature evaluation skills for pediatric ASP pharmacists.


Thomas Lodise, PharmD, PhD

Latest:

Advice for Physicians to Manage C. Difficile Infection (CDI)

Experts share advice for physicians taking care of patients with C. difficile infection (CDI).


Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc; and Ryan P. McNamara, PhD

Latest:

Influenza Vaccination With SARS-CoV-2 mRNA Booster Shots

Drs Jacinda Abdul-Mutakabbir, Madeline King, Rodney Rohde, and expert nurse practitioner Wendy Wright provide insight on receiving the influenza vaccine concurrently with the SARS-CoV-2 booster shot, and comment on data on immune responses from the Moderna and Pfizer/BioNTech vaccines.


Killian Meara

Latest:

Cognitive Symptoms Associated With Long COVID Linked to Greater Functional Impairment

Participants of a recent study who experienced more daily cognitive symptoms had a greater likelihood of reporting moderate interference with functioning, less likelihood of full-time employment, and greater severity of depressive symptoms.


James M. Crosby, DO

Latest:

Exploring the Recently Approved and Upcoming Clostridioides difficile Therapeutics

This market has seen a flurry of activity, as shown by a review of the latest agents.


Shmuel Shoham, MD

Latest:

COVID-19 Convalescent Plasma: What Is Its Role in Therapy?

The key is using the right dose on the right patient at the right time.


Aleena Issac, PharmD

Latest:

Treating Persistent Methicillin-susceptible Staphylococcus aureus (MSSA) Bacteremia

Emerging treatment options for patients with persistently positive blood cultures with Methicillin-Susceptible Staphylococcus aureus (MSSA).


Torey Roesch, MD

Latest:

A Review of the Currently Available Monoclonal Antibodies for COVID-19

Outside of vaccines, these underutilized therapies are the best defense against severe disease.


Eric Gregory, PharmD, BCIDP

Latest:

Vancomycin AUC Implementation in Resource-Limited Settings and its Associated Difficulties

The latest article from SIDP illustrates the challenges of area under the curve (AUC) implementation and offers insights for strategies and resources to overcome them.



Gavin H. Harris, MD

Latest:

Fever of Unknown Origin: What Do We Know and Where Do We Go?

As the number of etiologies increases, we must ground our application of new diagnostic modalities with appropriate assessments.


Alice Gallo De Moraes, MD

Latest:

Opposing Forces During COVID-19: Perspective From the ICU

Conflicting priorities of infection control, antimicrobial stewardship, and critical care make the management of sepsis secondary to SARS-CoV-2 infection challenging.


Daniel Escobar, MD

Latest:

Community-Acquired Candida Glabrata Empyema: An Atypical Diagnosis Not to Miss

Although this patient had none of these common risk factors associated with Candida empyema, she did have other factors predisposing her to fungal colonization and subsequent infection.


Donald Alcendor, PhD

Latest:

COVID-19 Booster Shots and the Future

Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.


Katelyn Kennedy, PharmD

Latest:

Oral Carbapenems: Promise, Peril, and Pushbacks

Here is a review of the literature for this class of antibiotics.


Albert Bach, PharmD

Latest:

What’s New With Non–COVID-19 Vaccines

Although COVID-19 vaccination remains the primary focus for health care, other paramount vaccines need to be recognized. Here is a review.


Jina Saltzman, PA-C

Latest:

Lessons in Resilience: What HIV Teaches Us About COVID-19

Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.


Jonathan Alicea

Latest:

Still Learning: Optimizing the Diagnosis and Screening of Respiratory Viruses

While the COVID-19 pandemic has helped advance respiratory diagnostics and surveillance, there are still many gaps that remain across the spectrum of healthcare.


Lauren R. Biehle, PharmD, BCPS, BCIDP

Latest:

Antimicrobial Stewardship: More Is Better

A robust stewardship program requires a comprehensive investment in technology and staff.


Bradley Langford, PharmD, BCIDP

Latest:

SHARE the Responsibility of Antibiotic Stewardship With Our Patients

How pharmacists can use shared decision-making to improve antibiotic use.


Priya Nori, MD

Latest:

Practice Pearls for Treatment of Respiratory Infections

Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, provide key takeaways from the discussion on the treatment of respiratory viral infections.


John Koethe, MD

Latest:

Multidisciplinary Perspectives on HIV Treatment

A multidisciplinary panel concludes a discussion on best practices for managing patients with HIV in various healthcare settings and overcoming social health disparities.



Takako S. Schaninger, MD

Latest:

Challenges in the Management of Mycobacterium abscessus Complex

This pathogen is the third most frequently isolated nontuberculous mycobacteria seen in the United States. Here is a review of how it presents and treatment options.



Frank J. Palella, MD

Latest:

Supporting Patients With HIV

Advice to community physicians regarding ways to enhance patient-provider relationships and navigate barriers that impact the management of HIV infections.

© 2024 MJH Life Sciences

All rights reserved.